Bank Julius Baer & Co. Ltd, Zurich Beam Therapeutics Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$29.86 - $62.36 $79,218 - $165,441	-2,653 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$53.73 - $82.16 $142,545 - $217,970	2,653 New	2,653 $152,000
Q2 2021 Jul 23, 2021	SELL	$64.12 - $128.71 $850,744 - $1.71 Million	-13,268 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$71.28 - $120.75 $945,743 - $1.6 Million	13,268 New	13,268 $1.06 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.